natgillin/translations-raw huggingface dataset:
Activyl Tick Plus Spot-on solution for dogs
Activyl Tick Plus Spot-on otopina za pse
Activyl Tick Plus spot-on solution for extra large dogs
Activyl Tick Plus spot-on otopina za jako velike pse
Activyl Tick Plus spot-on solution for large dogs
Activyl Tick Plus spot-on otopina za velike pse
Activyl Tick Plus spot-on solution for medium dogs
Activyl Tick Plus spot-on otopina za srednje velike pse
Activyl Tick Plus spot-on solution for small dogs
Activyl Tick Plus spot-on otopina za male pse
Activyl Tick Plus spot-on solution for very small dogs
Activyl Tick Plus spot-on otopina za jako male pse
Actos 15 mg tablets Actos 30 mg tablets Actos 45 mg tablets
Actos 15 mg tablete Actos 30 mg tablete Actos 45 mg tablete
Actos 15 mg tablets Actos 30 mg tablets Actos 45 mg tablets Pioglitazone
Actos 15 mg tablete Actos 30 mg tablete Actos 45 mg tablete pioglitazon
Actos 15 mg tablets are white to off white, round, convex tablets marked ‘15’ on one face and ‘ACTOS’ on the other face.
Actos 15 mg tablete su bijele do gotovo bijele boje, okrugle, konveksne s oznakom ‘15’ na jednoj strani i ‘ACTOS’ na drugoj strani.
Actos 15 mg tablets Pioglitazone
Actos 15 mg tablete pioglitazon
Actos 30 mg tablets are white to off white, round, flat tablets marked ‘30’ on one face and ‘ACTOS’ on the other face.
Actos 30 mg tablete su bijele do gotovo bijele boje, okrugle, plosnate s oznakom ‘30’ na jednoj strani i ‘ACTOS’ na drugoj strani.
Actos 30 mg tablets Pioglitazone
Actos 30 mg tablete pioglitazon
Actos 45 mg tablets are white to off white, round, flat tablets marked ‘45’ on one face and ‘ACTOS’ on the other face.
Actos 45 mg tablete su bijele do gotovo bijele boje, okrugle, plosnate s oznakom ‘45’ na jednoj strani i ‘ACTOS’ na drugoj strani.
Actos 45 mg tablets Pioglitazone
Actos 45 mg tablete pioglitazon
Actos led to a decrease in the level of HbA1c, indicating that blood glucose levels had been reduced at doses of 15, 30 and 45 mg.
Actos je doveo do smanjenja razine HbA1c, ukazujući na to da su razine glukoze u krvi smanjene pri primjeni doza od 15, 30 i 45 mg.
Actos on its own was shown to be as effective as metformin and gliclazide.
Actos se pri samostalnoj primjeni pokazao jednako učinkovitim kao i metformin i gliklazid.
Actos tablets contain lactose monohydrate and therefore should not be administered to patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption.
Tablete Actos sadrže laktozu hidrat te se stoga ne smiju primjenjivati u bolesnika s rijetkim nasljednim poremećajima nepodnošenja galaktoze, nedostatka Lapp laktaze ili malapsorpcijom glukoze- galaktoze.
Actos with food and drink
Actos s hranom i pićem
Actraphane 30 100 international units/ml Suspension for injection
Actraphane 30 100 internacionalnih jedinica/ml Suspenzija za injekciju
Actraphane 30 100 international units/ml suspension for injection in vial human insulin
Actraphane 30 100 internacionalnih jedinica/ml suspenzija za injekciju u bočici humani inzulin
Actraphane 30 100 international units/ml suspension for injection.
Actraphane 30 100 internacionalnih jedinica/ml suspenzija za injekciju.
Actraphane 30 40 international units/ml Suspension for injection
Actraphane 30 40 internacionalnih jedinica/ml Suspenzija za injekciju
Actraphane 30 40 international units/ml suspension for injection in vial human insulin
Actraphane 30 40 internacionalnih jedinica/ml suspenzija za injekciju u bočici humani inzulin
Actraphane 30 40 international units/ml suspension for injection.
Actraphane 30 40 internacionalnih jedinica/ml suspenzija za injekciju.
Actraphane 30 contains less than 1 mmol sodium (23 mg) per dose, i.e.
Actraphane 30 sadrži manje od 1 mmol (23 mg) natrija po dozi tj.
Actraphane 30 FlexPen 100 international units/ml Suspension for injection
Actraphane 30 FlexPen 100 internacionalnih jedinica/ml Suspenzija za injekciju
Actraphane 30 FlexPen 100 international units/ml suspension for injection in pre-filled pen human insulin
Actraphane 30 FlexPen 100 internacionalnih jedinica/ml suspenzija za injekciju u napunjenoj brizgalici humani inzulin
Actraphane 30 FlexPen is a pre-filled disposable pen containing a mixture of fast-acting and long- acting human insulin in the ratio 30/70.
Actraphane 30 FlexPen je jednokratna napunjena brizgalica koja sadrži mješavinu brzodjelujućeg i dugodjelujućeg humanog inzulina u omjeru 30/70.
Actraphane 30 InnoLet 100 international units/ml Suspension for injection
Actraphane 30 InnoLet 100 internacionalnih jedinica/ml Suspenzija za injekciju
Actraphane 30 InnoLet 100 international units/ml suspension for injection in pre-filled pen human insulin
Actraphane 30 InnoLet 100 internacionalnih jedinica/ml suspenzija za injekciju u napunjenoj brizgalici humani inzulin
Actraphane 30 InnoLet is a pre-filled disposable pen containing a mixture of fast-acting and long- acting human insulin in the ratio 30/70.
Actraphane 30 InnoLet je jednokratna napunjena brizgalica koja sadrži mješavinu brzodjelujućeg i dugodjelujućeg humanog inzulina u omjeru 30/70.
Actraphane 30 InnoLet, Actraphane 40 and 50 Penfill:
Actraphane 30 InnoLet, Actraphane 40 i 50 Penfill:
Actraphane 30 is essentially ‘sodium-free’.
Actraphane 30 sadrži zanemarive količine natrija.
Actraphane 30 Penfill 100 international units/ml Suspension for injection
Actraphane 30 Penfill 100 internacionalnih jedinica/ml Suspenzija za injekciju
Actraphane 30 Penfill 100 international units/ml suspension for injection in cartridge human insulin
Actraphane 30 Penfill 100 internacionalnih jedinica/ml suspenzija za injekciju u ulošku humani inzulin
ACTRAPHANE 30 suspension for injection in pre-filled pen.
ACTRAPHANE 30 suspenzija za injekciju u napunjenoj brizgalici.
Actraphane 30 vial, Penfill and FlexPen:
Actraphane 30 bočica, Penfill i FlexPen:
Actraphane 30: soluble insulin 30% and isophane insulin 70%;
Actraphane 30: topljivi inzulin 30% i izofan inzulin 70%;
Actraphane 40 contains less than 1 mmol sodium (23 mg) per dose, i.e.
Actraphane 40 sadrži manje od 1 mmol (23 mg) natrija po dozi tj.
Actraphane 40 is essentially ‘sodium-free’.
Actraphane 40 sadrži zanemarive količine natrija.
Actraphane 40 Penfill 100 international units/ml Suspension for injection
Actraphane 40 Penfill 100 internacionalnih jedinica/ml Suspenzija za injekciju
Actraphane 40 Penfill 100 international units/ml suspension for injection in cartridge human insulin
Actraphane 40 Penfill 100 internacionalnih jedinica/ml suspenzija za injekciju u ulošku humani inzulin
Actraphane 40: soluble insulin 40% and isophane insulin 60%;
Actraphane 40: topljivi inzulin 40% i izofan inzulin 60%;
Actraphane 50 contains less than 1 mmol sodium (23 mg) per dose, i.e.
Actraphane 50 sadrži manje od 1 mmol (23 mg) natrija po dozi tj.
Actraphane 50 is essentially ‘sodium-free’.
Actraphane 50 sadrži zanemarive količine natrija.
Actraphane 50 Penfill 100 international units/ml Suspension for injection
Actraphane 50 Penfill 100 internacionalnih jedinica/ml Suspenzija za injekciju
Actraphane 50 Penfill 100 international units/ml suspension for injection in cartridge human insulin
Actraphane 50 Penfill 100 internacionalnih jedinica/ml suspenzija za injekciju u ulošku humani inzulin
Actraphane 50: soluble insulin 50% and isophane insulin 50%.
Actraphane 50: topljivi inzulin 50% i izofan inzulin 50%;
Actraphane can be used in children and adolescents.
Actraphane se može primjenjivati u djece i adolescenata.
Actraphane contains less than 1 mmol sodium (23 mg) per dose, i.e.
Actraphane sadrži manje od 1 mmol (23 mg) natrija po dozi, tj.
Actraphane contains sodium
Actraphane sadrži natrij
Actraphane FlexPen is a pre-filled pen designed to be used with NovoFine or NovoTwist disposable needles up to a length of 8 mm.
Actraphane FlexPen je napunjena brizgalica namijenjena uporabi s jednokratnim iglama NovoFine ili NovoTwist duljine do 8 mm.
Actraphane FlexPen is accompanied by a package leaflet with detailed instructions for use to be followed.
Uz Actraphane FlexPen priložena je Uputa o lijeku s detaljnim naputcima za primjenu koje treba slijediti.
Actraphane human insulin
Actraphane humani inzulin
Actraphane InnoLet is a pre-filled pen designed to be used with NovoFine or NovoTwist disposable needles up to a length of 8 mm.
Actraphane InnoLet je napunjena brizgalica namijenjena uporabi s jednokratnim iglama NovoFine ili NovoTwist duljine do 8 mm.
Actraphane InnoLet is accompanied by a package leaflet with detailed instructions for use to be followed.
Uz Actraphane InnoLet priložena je Uputa o lijeku s detaljnim naputcima za primjenu koje treba slijediti.
Actraphane is essentially ‘sodium-free’.
Actraphane sadrži zanemarive količine natrija.
Actraphane Penfill is accompanied by a package leaflet with detailed instructions for use to be followed.
Uz Actraphane Penfill priložena je Uputa o lijeku s detaljnim naputcima za primjenu koje treba slijediti.
Actraphane Penfill is designed to be used with Novo Nordisk insulin delivery systems and NovoFine or NovoTwist needles.
Actraphane Penfill je namijenjen uporabi s pomagalima za primjenu inzulina proizvođača Novo Nordisk i iglama NovoFine ili NovoTwist.
Actraphane vial is accompanied by a package leaflet with detailed instructions for use to be followed.
Uz Actraphane bočicu priložena je Uputa o lijeku s detaljnim naputcima za primjenu koje treba slijediti.
Actraphane vials are for use with insulin syringes with the corresponding unit scale.
Actraphane bočice koriste se s inzulinskim štrcaljkama s odgovarajućom jediničnom skalom.
Actrapid 100 international units/ml solution for injection in vial human insulin
Actrapid 100 internacionalnih jedinica/ml otopina za injekciju u bočici humani inzulin
Actrapid 100 international units/ml solution for injection.
Actrapid 100 internacionalnih jedinica/ml otopina za injekciju.
Actrapid 40 international units/ml solution for injection in vial human insulin
Actrapid 40 internacionalnih jedinica/ml otopina za injekciju u bočici humani inzulin
Actrapid 40 international units/ml solution for injection.
Actrapid 40 internacionalnih jedinica/ml otopina za injekciju.
Actrapid can be used in children and adolescents.
Actrapid se može primjenjivati u djece i adolescenata.
Actrapid contains less than 1 mmol sodium (23 mg) per dose, i.e.
Actrapid sadrži manje od 1 mmol (23 mg) natrija po dozi tj.
Actrapid contains less than 1 mmol sodium (23 mg) per dose, i.e.
Actrapid sadrži manje od 1 mmol (23 mg) natrija po dozi, tj.
Actrapid FlexPen 100 international units/ml Solution for injection
Actrapid FlexPen 100 internacionalnih jedinica/ml Otopina za injekciju
Actrapid FlexPen 100 international units/ml solution for injection in pre-filled pen human insulin
Actrapid FlexPen 100 internacionalnih jedinica/ml otopina za injekciju u napunjenoj brizgalici humani inzulin
Actrapid FlexPen 100 international units/ml Solution for injection in pre-filled pen Insulin human
Actrapid FlexPen 100 internacionalnih jedinica/ml Otopina za injekciju u napunjenoj brizgalici humani inzulin
Actrapid FlexPen is a pre-filled pen designed to be used with NovoFine or NovoTwist disposable needles up to a length of 8 mm.
Actrapid FlexPen je napunjena brizgalica namijenjena uporabi s jednokratnim iglama NovoFine ili NovoTwist duljine do 8 mm.
Actrapid FlexPen is accompanied by a package leaflet with detailed instructions for use to be followed.
Uz Actrapid FlexPen priložena je Uputa o lijeku s detaljnim naputcima za primjenu koje treba slijediti.
Actrapid InnoLet 100 international units/ml Solution for injection
Actrapid InnoLet 100 internacionalnih jedinica/ml Otopina za injekciju
Actrapid InnoLet 100 international units/ml solution for injection in pre-filled pen human insulin
Actrapid InnoLet 100 internacionalnih jedinica/ml otopina za injekciju u napunjenoj brizgalici humani inzulin
Actrapid InnoLet 100 international units/ml Solution for injection in pre-filled pen Insulin human
Actrapid InnoLet 100 internacionalnih jedinica/ml Otopina za injekciju u napunjenoj brizgalici humani inzulin
Actrapid InnoLet is a pre-filled pen designed to be used with NovoFine or NovoTwist disposable needles up to a length of 8 mm.
Actrapid InnoLet je napunjena brizgalica namijenjena uporabi s jednokratnim iglama NovoFine ili NovoTwist duljine do 8 mm.
Actrapid InnoLet is accompanied by a package leaflet with detailed instructions for use to be followed.
Uz Actrapid InnoLet priložena je Uputa o lijeku s detaljnim naputcima za primjenu koje treba slijediti.
Actrapid is a fast-acting human insulin and may be used in combination with intermediate or long- acting insulin medicinal products.
Actrapid je brzodjelujući humani inzulin i može se koristiti u kombinaciji sa srednjedugodjelujućim ili dugodjelujućim inzulinskim pripravcima.
Actrapid is essentially ‘sodium- free’.
Actrapid sadrži zanemarive količine natrija.
Actrapid Penfill 100 international units/ml Solution for injection
Actrapid Penfill 100 internacionalnih jedinica/ml Otopina za injekciju
Actrapid Penfill 100 international units/ml solution for injection in cartridge human insulin
Actrapid Penfill 100 internacionalnih jedinica/ml otopina za injekciju u ulošku humani inzulin
Actrapid Penfill is accompanied by a package leaflet with detailed instructions for use to be followed.
Uz Actrapid Penfill priložena je Uputa o lijeku s detaljnim naputcima za primjenu koje treba slijediti.
ACTRAPID solution for injection in pre-filled pen.
ACTRAPID otopina za injekciju u napunjenoj brizgalici.
Actrapid vial is accompanied by a package leaflet with detailed instructions for use to be followed.
Uz Actrapid bočicu priložena je Uputa o lijeku s detaljnim naputcima za primjenu koje treba slijediti.
Actrapid vial, Penfill and FlexPen:
Actrapid bočica, Penfill i FlexPen:
Actrapid vials are for use with insulin syringes with the corresponding unit scale.
Actrapid bočice koriste se s inzulinskim štrcaljkama s odgovarajućom jediničnom skalom.
Actual MedDRA terms included are abdominal discomfort, abdominal pain, abdominal pain lower, abdominal pain upper, and stomach discomfort.
Obuhvaća MedDRA termine: nelagoda u abdomenu, bol u abdomenu, bol u donjem dijelu abdomena, bol u gornjem dijelu abdomena i nelagoda u želucu.
Actually 79 patients were identified by absence of an M918T mutation and no RET mutation identified at any of the other 6 exons tested but in 71 of such patients sequencing of the 6 exons was incomplete.
U stvarnosti je pronađeno 79 bolesnika u kojih nije postojala mutacija M918T niti RET mutacija na bilo kojem od ostalih 6 ispitanih eksona; no, u 71 takvog bolesnika je sekvenciranje 6 eksona bilo nepotpuno.
Acture respiratory distress syndrome, interstitial pneumonia/pneumonitis, interstitial lung disease, pulmonary fibrosis and respiratory failure have been reported and may be associated with fatal outcome.
Prijavljeni su akutni respiratorni distres sindrom, intersticijska pneumonija/pneumonitis, intersticijska bolest pluća, plućna fibroza i zatajenje disanja, koji mogu biti povezani sa smrtnim ishodima.
ACUITY Trial (Patients with unstable angina/non-ST segment elevated myocardial infarction (UA/NSTEMI)
ACUITY ispitivanje (bolesnici s nestabilnom anginom/infarktom miokarda bez elevacije ST segmenta (UA/NSTEMI))
ACUITY trial; 30-day and 1-year risk differences for the composite ischaemic endpoint and its components for patients that received acetylsalicylic acid and clopidogrel as per protocol*
Ispitivanje ACUITY: 30-dnevne i 1-godišnje razlike rizika za ishemijski kompozitni ishod i njegovih komponenata u bolesnika koji su dobivali acetilsalicilatnu kiselinu i klopidogrel prema planu ispitivanja
ACUITY trial; 30-day and 1-year risk differences for the composite ischaemic endpoint and its components for the overall population (ITT)
Ispitivanje ACUITY: 30-dnevne i 1-godišnje razlike rizika za ishemijski kompozitni ishod i njegovih komponenata za cjelokupnu populaciju (ITT)
ACUITY trial; bleeding events up to day 30 for the population of patients who received acetylsalicylic acid and clopidogrel as per protocol*
Ispitivanje ACUITY; krvarenja unutar 30 dana za populaciju bolesnika koji su primali acetilsalicilatnu kiselinu i klopidogrel prema planu ispitivanja
Acute (single-dose) toxicity
Hematološka toksičnost
acute accumulation of fluid in the lungs
akutno nakupljanje tekućine u plućima
Acute adrenal insufficiency
Akutna adrenalna insuficijencija
Acute alcohol intoxication, alcoholism
Akutna intoksikacija alkoholom, alkoholizam
Acute alcohol intoxication, alcoholism
akutno trovanje alkoholom, alkoholizam
acute alcohol intoxication, alcoholism; breast-feeding.
akutnim trovanjem alkoholom, alkoholizmom; koji doje.
acute and
akutni i
Acute and chronic musculo-skeletal disorders.
Akutni i kronični mišićno-koštani poremećaji.
acute and chronic pancreatitis, ileus paralytic, gastrooesophageal reflux disease, impaired gastric emptying
akutni i kronični pankreatitis, paralitički ileus, gastrooezofagealna refluksna bolest, poremećeno želučano pražnjenje
Acute and delayed systemic reactions, including hypersensitivity reactions (e.g. urticaria, angioedema, rash, bronchospasm, hypotension), have occurred following administration of Nucala.
Nakon primjene lijeka Nucala nastupile su akutne i odgođene sistemske reakcije, uključujući reakcije preosjetljivosti (npr. urtikarija, angioedem, osip, bronhospazam, hipotenzija).
acute bacterial endocarditis severe renal impairment defined by creatinine clearance < 20 ml/min.
akutni bakterijski endokarditis teško oštećenje bubrega definirano kao klirens kreatinina < 20 ml/min.
acute bacterial endocarditis severe renal impairment defined by creatinine clearance < 30 ml/min.
akutni bakterijski endokarditis teško oštećenje bubrega definirano kao klirens kreatinina <30 ml/min.
Acute bacterial endocarditis,
Akutni bakterijski endokarditis
Acute bacterial endocarditis,
Akutni bakterijski endokarditis,
acute bleeding from the lungs may result in coughing up blood, cases with fatal outcomes were observed (uncommon side effect).
akutno krvarenje iz pluća može rezultirati iskašljavanjem krvi, zabilježeni su slučajevi sa smrtnim ishodom (manje česta nuspojava).
acute bleeding ≥240 ml in a 24-hour period recurrent bleeding ≥100 ml/day over several days
akutno krvarenje ≥ 240 ml tijekom razdoblja od 24 sata opetovano krvarenje ≥ 100 ml/dan tijekom nekoliko dana
Acute breathing difficulty, chest pain, swelling of the face (mouth, lips and around eyes), fluid accumulation in the lungs
akutno otežano disanje, bol u prsima, oticanje lica (usne šupljine, usana i oko očiju), nakupljanje tekućine u plućima
Acute breathlessness
akutni nedostatak zraka
Acute breathlessness
trenutno nastao nedostatak zraka
Acute cases and severely diseased pigs with reduced food and water intake should be treated with a suitable injectable product.
Akutne slučajeve teško oboljelih svinja koje unose manje hrane i vode treba liječiti odgovarajućim proizvodom u obliku za injekciju.
Acute cases and severely diseased pigs with reduced food and water intake should be treated with a suitable injectable veterinary medicinal product.
Akutne slučajeve teško oboljelih svinja koje unose manje hrane i vode treba liječiti odgovarajućim veterinarsko-medicinskim proizvodom za ubrizgavanje.
Acute cases and severely diseased pigs with reduced food or water intake should be treated with a suitable injectable product.
Akutne slučajeve teško oboljelih svinja koje unose manje hrane ili vode treba liječiti odgovarajućim proizvodom u obliku za injiciranje.
Acute cases and severely diseased pigs with reduced food or water intake should be treated with a suitable injectable veterinary medicinal product.
Akutne slučajeve teško oboljelih svinja koje unose manje hrane ili vode treba liječiti odgovarajućim veterinarsko-medicinskim proizvodom u obliku za injicaranje.
Acute chest syndrome is a frequent life-threatening complication of Sickle Cell Syndrome and is characterised by chest pain or fever or dyspnoea with recent infiltrate on chest X-ray.
Akutni prsni sindrom česta je komplikacija sindroma srpastih stanica koja može ugroziti život i koju karakterizira bol u prsnom košu ili vrućica ili dispneja uz novonastali infiltrat uočen na rendgenskoj snimciprsnog koša..
Acute conditions with the potential to alter renal function such as:
akutna stanja koja mogu oštetiti funkciju bubrega kao što su:
Acute conditions with the potential to alter renal function such as:
akutna stanja koja mogu promijeniti funkciju bubrega kao što su:
Acute conditions with the potential to alter renal function such as:
akutna stanja koja mogu utjecati na funkciju bubrega kao što su:
acute conditions with the potential to alter renal function such as:
akutnim stanjima koja mogu utjecati na funkciju bubrega kao što su:
Acute conditions with the potential to alter renal function such as: dehydration, severe infection, shock (see section 4.4);
Akutna stanja s potencijalom promjene bubrežne funkcije kao što su: dehidracija, teška infekcija, šok (vijdeti dio 4.4);
Acute conditions with the potential to alter renal function such as: dehydration, severe infection, shock.
Akutna stanja koja mogu promijeniti bubrežnu funkciju poput: dehidracije, teške infekcije, šoka.
Acute conditions with the potential to alter renal function such as: dehydration, severe infection, shock.
Akutna stanja koja mogu promijeniti funkciju bubrega poput: dehidracije, teške infekcije, šoka.
Acute conditions with the potential to alter renal function, such as:
Akutna stanja koja mogu promijeniti funkciju bubrega, kao što su:
acute confusion, seizures (epilepsy), coma, a combination of fever, faster breathing, sweating, muscle stiffness, and drowsiness or sleepiness, slower breathing, choking, high or low blood pressure, abnormal rhythms of the heart.
akutnu smetenost, napadaje (epilepsiju), komu, kombinaciju vrućice, ubrzanog disanja, znojenja, ukočenosti mišića i omamljenosti ili pospanosti, usporeno disanje, gušenje, visok ili nizak krvni tlak, abnormalni srčani ritam.
Acute coronary syndrome (including myocardial infarction) within the last 30 days
Akutni koronarni sindrom (uključujući infarkt miokarda) u prethodnih 30 dana.
Acute coronary syndrome (including myocardial infarction) within the last 30 days.
Akutni koronarni sindrom (uključujući infarkt miokarda) u prethodnih 30 dana.
acute coronary syndrome, atrioventricular block second degree, aortic valve disease, arrhythmia supraventricular
akutni koronarni sindrom, atrioventrikularni blok drugog stupnja, bolest aortalne valvule, supraventrikularna aritmija
acute disability are resolved.
ve do prestanka boli i akutne
Acute disseminated encephalomyelitis*, Dizziness1 *, Guillain-Barré syndrome*, syncope sometimes accompanied by tonic-clonic movements*
akutni diseminirani encefalomijelitis*, omaglica1 *, Guillain-Barréov sindrom*, sinkopa ponekad popraćena toničko-kloničkim pokretima
Acute exacerbation of chronic bronchitis: 800 mg once a day for 5 days,
akutna egzacerbacija kroničnog bronhitisa: 800 mg jedanput na dan tijekom 5 dana,
Acute exacerbation of hepatitis has been reported in patients on treatment as well as in patients who have discontinued hepatitis B therapy (see section 4.4).
Akutna egzacerbacija hepatitisa zabilježena je u pacijenata koji su se liječili, kao i u onih koji su prekinuli terapiju hepatitisa B (vidjeti dio 4.4).
Acute exposure is not significantly influenced by gender, history of congestive heart failure, renal impairment, or concomitant administration of beta blockers and other medications, including warfarin, metoprolol, furosemide and digoxin.
Na akutnu izloženost nisu značajno utjecali spol, anamneza kongestivnog zatajenja srca, oštećenje funkcije bubrega ni istodobna primjena beta blokatora i drugih lijekova, uključujući varfarin, metoprolol, furosemid i digoksin.
Acute failure of the kidney’s functions
Akutno zatajenje funkcije bubrega
acute febrile neutrophilic dermatosis (Sweet’s syndrome)
akutna febrilna neutrofilna dermatoza (Sweetov sindrom)